| Name | Wiley Mission |
|---|---|
| Location | 99 East Main Street, Marlton, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 86 |
| Occupancy Rate | 50.35% |
| Medicare ID (CCN) | 315418 |
| Legal Business Name | Wiley Mission |
| Ownership Type | Non Profit - Church Related |
| NPI Number | 1821126541 |
| Organization Name | WILEY MISSION |
| Address | 99 E Main St, Marlton, NJ 08053 |
| Phone Number | 856-983-0411 |
News Archive
Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced additional data from the Phase III clinical trial for its serum protein test, VeriStrat. Results were presented at the 15th World Conference on Lung Cancer in Sydney, Australia.
An international team that includes researchers from the National Human Genome Research Institute (NHGRI) has discovered that mammalian chromosomes have evolved by breaking at specific sites rather than randomly as long thought - and that many of the breakage hotspots are also involved in human cancer.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Cardiome Pharma Corp. today announced results from a Phase 3 clinical study conducted with BRINAVESS (vernakalant intravenous, RSD 1235) in the Asia-Pacific (A-P) region.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced additional data from the Phase III clinical trial for its serum protein test, VeriStrat. Results were presented at the 15th World Conference on Lung Cancer in Sydney, Australia.
An international team that includes researchers from the National Human Genome Research Institute (NHGRI) has discovered that mammalian chromosomes have evolved by breaking at specific sites rather than randomly as long thought - and that many of the breakage hotspots are also involved in human cancer.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Cardiome Pharma Corp. today announced results from a Phase 3 clinical study conducted with BRINAVESS (vernakalant intravenous, RSD 1235) in the Asia-Pacific (A-P) region.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.59 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.76 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 71.19 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.52 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.14 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 8.67 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.41 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.4 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.81 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 79.31 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.1 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 31.82 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.66 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 71.85 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 70.83 | 82.93 |
News Archive
Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced additional data from the Phase III clinical trial for its serum protein test, VeriStrat. Results were presented at the 15th World Conference on Lung Cancer in Sydney, Australia.
An international team that includes researchers from the National Human Genome Research Institute (NHGRI) has discovered that mammalian chromosomes have evolved by breaking at specific sites rather than randomly as long thought - and that many of the breakage hotspots are also involved in human cancer.
Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.
Cardiome Pharma Corp. today announced results from a Phase 3 clinical study conducted with BRINAVESS (vernakalant intravenous, RSD 1235) in the Asia-Pacific (A-P) region.
› Verified 2 days ago